DEL GIUDICE, TERESA
 Distribuzione geografica
Continente #
AS - Asia 63
NA - Nord America 59
EU - Europa 31
SA - Sud America 25
AF - Africa 3
Totale 181
Nazione #
US - Stati Uniti d'America 56
SG - Singapore 26
BR - Brasile 17
VN - Vietnam 17
DE - Germania 14
IN - India 8
CN - Cina 6
GB - Regno Unito 5
SE - Svezia 5
FI - Finlandia 3
MX - Messico 3
AR - Argentina 2
EC - Ecuador 2
IT - Italia 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
HK - Hong Kong 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
MA - Marocco 1
PY - Paraguay 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 181
Città #
Munich 13
Singapore 12
Chandler 6
Bengaluru 5
Dallas 5
Hanoi 5
Hefei 5
Santa Clara 4
Chicago 3
London 3
Turku 3
Ashburn 2
Chennai 2
Haiphong 2
Ho Chi Minh City 2
Lawrence 2
Milan 2
Princeton 2
Amman 1
Asunción 1
Atlanta 1
Biên Hòa 1
Boardman 1
Boston 1
Brooklyn 1
Buffalo 1
Bắc Giang 1
Campinas 1
Candeias 1
Canoas 1
Caucaia 1
Concordia 1
Corona 1
Darregueira 1
Fes 1
Gravataí 1
Guadalajara 1
Guarulhos 1
Hong Kong 1
Hòa Bình 1
Hải Dương 1
Iporá 1
Irving 1
Itacaré 1
Johannesburg 1
Kolkata 1
Kramfors 1
Long An 1
Manado 1
Maturín 1
Menzel Temime 1
Mexico City 1
Montevideo 1
Muriaé 1
Niterói 1
Norwalk 1
Padre Las Casas 1
Pedreira 1
Phoenix 1
Pittsburgh 1
Poplar 1
Porto Velho 1
Portoviejo 1
Quito 1
Raleigh 1
Reriutaba 1
Rio de Janeiro 1
Saint Louis 1
San Francisco 1
Shenzhen 1
São João da Barra 1
São Paulo 1
Taboão da Serra 1
Thái Bình 1
Tokyo 1
Wilmington 1
Wisbech 1
Totale 137
Nome #
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 68
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 43
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 35
Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications 26
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 15
Totale 187
Categoria #
all - tutte 1.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 3 0 0 0 0 0 0
2021/20227 0 0 0 3 0 0 0 1 1 2 0 0
2022/202324 4 1 2 0 3 1 0 2 6 2 2 1
2023/20248 4 0 0 0 1 2 0 0 0 0 0 1
2024/202566 3 0 4 1 3 8 2 1 7 0 15 22
2025/202679 11 16 25 27 0 0 0 0 0 0 0 0
Totale 187